2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Pellficure Pharmaceuticals, Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of PCUR-101 in Combination With ADT in Patients With mCRPC PCUR-101, Dutasteride 0.5 mg, Abiraterone and Prednisone - Prostate Cancer | Phase 1 | Terminated | Pellficure Pharmaceuticals, Inc | 7 | 2021-03-30 | 2024-04-10 |
| A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer PCUR - 101 - Metastatic Castration-Resistant Prostate Cancer | Phase 1 | Terminated | Pellficure Pharmaceuticals, Inc | 12 | 2017-07-24 | 2020-03-09 |
Dutasteride (1) · Prednisone (1) · abiraterone (1)
United States (2) · Australia (1)